135 related articles for article (PubMed ID: 19055945)
1. Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis.
Sionov RV; Spokoini R; Kfir-Erenfeld S; Cohen O; Yefenof E
Adv Cancer Res; 2008; 101():127-248. PubMed ID: 19055945
[TBL] [Abstract][Full Text] [Related]
2. [The kinome and glucocorticoid-induced apoptosis].
Sionov RV
Ai Zheng; 2008 Nov; 27(11):1121-9. PubMed ID: 19000440
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
Greenstein S; Ghias K; Krett NL; Rosen ST
Clin Cancer Res; 2002 Jun; 8(6):1681-94. PubMed ID: 12060604
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.
Spokoini R; Kfir-Erenfeld S; Yefenof E; Sionov RV
Mol Endocrinol; 2010 Jun; 24(6):1136-50. PubMed ID: 20371704
[TBL] [Abstract][Full Text] [Related]
5. Non-genomic events determining the sensitivity of hemopoietic malignancies to glucocorticoid-induced apoptosis.
Kfir-Erenfeld S; Yefenof E
Cancer Immunol Immunother; 2014 Jan; 63(1):37-43. PubMed ID: 24072402
[TBL] [Abstract][Full Text] [Related]
6. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.
Kfir-Erenfeld S; Sionov RV; Spokoini R; Cohen O; Yefenof E
Leuk Lymphoma; 2010 Nov; 51(11):1968-2005. PubMed ID: 20849387
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.
Schmidt S; Rainer J; Ploner C; Presul E; Riml S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S45-55. PubMed ID: 15243581
[TBL] [Abstract][Full Text] [Related]
10. The glucocorticoid receptor mediates the thymic epithelial cell-induced apoptosis of CD4+8+ thymic lymphoma cells.
Zilberman Y; Zafrir E; Ovadia H; Yefenof E; Guy R; Sionov RV
Cell Immunol; 2004 Jan; 227(1):12-23. PubMed ID: 15051511
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
Schlossmacher G; Stevens A; White A
J Endocrinol; 2011 Oct; 211(1):17-25. PubMed ID: 21602312
[TBL] [Abstract][Full Text] [Related]
12. Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells.
Boldizsar F; Talaber G; Szabo M; Bartis D; Palinkas L; Nemeth P; Berki T
Immunobiology; 2010 Jul; 215(7):521-6. PubMed ID: 19906460
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
Löwenberg M; Verhaar AP; van den Brink GR; Hommes DW
Trends Mol Med; 2007 Apr; 13(4):158-63. PubMed ID: 17293163
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
[TBL] [Abstract][Full Text] [Related]
15. Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
Huang WC; Tsai CC; Chen CL; Chen TY; Chen YP; Lin YS; Lu PJ; Lin CM; Wang SH; Tsao CW; Wang CY; Cheng YL; Hsieh CY; Tseng PC; Lin CF
FASEB J; 2011 Oct; 25(10):3661-73. PubMed ID: 21705667
[TBL] [Abstract][Full Text] [Related]
16. Sequence-specific transcription factors during glucocorticoid-induced apoptosis in acute lymphoblastic leukemia cells.
Hartmann BL; Geley S; Kofler R
Wien Klin Wochenschr; 1999 May; 111(9):360-7. PubMed ID: 10407997
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear regulation of commitment to apoptosis by simultaneous inhibition of Bcl-2 and XIAP in leukemia and lymphoma cells.
Skommer J; Das SC; Nair A; Brittain T; Raychaudhuri S
Apoptosis; 2011 Jun; 16(6):619-26. PubMed ID: 21442307
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis.
Hartmann BL; Geley S; Löffler M; Hattmannstorfer R; Strasser-Wozak EM; Auer B; Kofler R
Oncogene; 1999 Jan; 18(3):713-9. PubMed ID: 9989821
[TBL] [Abstract][Full Text] [Related]
19. Correlation of membrane glucocorticoid receptor levels with glucocorticoid-induced apoptotic competence using mutant leukemic and lymphoma cells lines.
Gametchu B; Watson CS
J Cell Biochem; 2002; 87(2):133-46. PubMed ID: 12244567
[TBL] [Abstract][Full Text] [Related]
20. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
Wei G; Twomey D; Lamb J; Schlis K; Agarwal J; Stam RW; Opferman JT; Sallan SE; den Boer ML; Pieters R; Golub TR; Armstrong SA
Cancer Cell; 2006 Oct; 10(4):331-42. PubMed ID: 17010674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
